FDA approves Telix's Pixclara for glioma imagingSep 14Regulatory decisionfloretyrosine f 18Telix Pharmaceuticals Ltd
Telix reports 22% H1 2026 revenue growth, guides to upper end of FY targetsAug 19Clinical readoutTelix Pharmaceuticals Ltd
Sign inSign in